Evolution of Fatigue in Patients With Inflammatory Bowel Disease
Visão geral do estudo
Status
Descrição detalhada
Fatigue is a common symptom in inflammatory bowel disease and persists despite clinical remission. Fatigue in patients with chronic diseases can be objectified by the FACIT-F scale.
Recent publications have tried to assess the prevalence and factors related to fatigue in patients with IBD.
In 2017 one study evaluated the prevalence and predictive factors of fatigue in out-patients with inflammatory bowel disease. Fatigue was associated with depression, low quality of life and female sex. No association was found with micronutrients or levels of interleukins.
As there are no effective treatments for fatigue in IBD, another study, recently published a study evaluating the role of electroacupuncture in 54 patients with quiescent IBD and fatigue, observing that both electroacupuncture and sham acupuncture improved fatigue compared to the control group.
The aim of this study is to evaluate the evolution and possible factors associated with the persistence of fatigue in patients with quiescent IBD and fatigue included in the two previous studies.
Patients with inflammatory bowel disease and fatigue (FACIT-F score < 40) included in these two previous studies who agree to participate will fill in questionnaires to assess fatigue, anxiety, depression and quality of life in inflammatory bowel disease. Moreover, the relationship of other biological factors with IBD-related fatigue will be determined.
Tipo de estudo
Inscrição (Antecipado)
Contactos e Locais
Contato de estudo
- Nome: Diana Horta
- Número de telefone: 93 745 84 54
- E-mail: diana.horta.s@gmail.com
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Método de amostragem
População do estudo
Descrição
Inclusion Criteria:
- Patients with inflammatory bowel disease and fatigue (defined as a FACIT-F score <40 points) previously documented in our two previous studies.
- Written informed consent after receiving clear and objective information about the purpose and characteristics of the study.
- Ability to understand the questionnaires.
Exclusion Criteria:
- Associated tumor disease.
- Pregnancy or breastfeeding.
- Anemia (hemoglobin <12g/dl in women and 14g/dl in men)
- Any concomitant illness that may justify the presence of fatigue.
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
Coortes e Intervenções
Grupo / Coorte |
|---|
|
Patients with Inflammatory Bowel Disease and fatigue
Patients with Inflammatory Bowel Disease and fatigue that participated in the two studies (1,2).
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Evaluate the evolution of fatigue in patients with Inflammatory Bowel Disease at 3 years
Prazo: three years
|
Assessed by the Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F scale).
This questionnaire, previously validated in Spanish and for IBD patients, comprises 40 items divided into five subscales: Physical wellbeing (PWB), Social/family wellbeing (SWB), Emotional wellbeing (EWB), Functional Wellbeing (FWB), and Fatigue subscale.
The first four subscales (27 items) evaluate general features of chronic illness, and the 13 items of the Fatigue subscale specifically focus on fatigue.
Each item has five possible answers, from 0 (very fatigued) to 4 (not at all fatigued).
The score of each subscale is the sum of the coded values of its items.
|
three years
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Assess the biological factors associated with the persistence of fatigue
Prazo: three years
|
Assessed by a blood test including micronutrients (vitamin B12, ferritin and vitamin D).
|
three years
|
|
Assess the psychological factors associated with the persistence of fatigue
Prazo: three years
|
Assessed by the Beck Depression Inventory (BDI) questionnaire.
The Spanish validated 21-item version of the BDI will be used to analyze depression.
This self-administered questionnaire evaluates the clinical features of melancholy and intrusive thoughts present in depression.
Each item has a different number of options (from 4 to 8), which then have to be converted into four possible values (0, 1, 2, or 3).
Higher BDI scores indicate a higher grade of depression.
|
three years
|
|
Assess the psychological factors associated with the persistence of fatigue
Prazo: three years
|
Assessed by Quality of life in inflammatory bowel disease questionnaire (IBDQ-9).
he IBDQ-9 consists of nine items assessing different aspects of life in IBD patients.
Each item has seven different possible answers, scoring from 1 (poorest) to 7 (best).
The straight summation of all nine items provides a direct score, which is then transformed into a final score.
Higher scores correspond to a better quality of life.
|
three years
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: Diana Horta, Parc Tauli Hospital. Sabadell , Barcelona, Spain, 08208
Publicações e links úteis
Publicações Gerais
- Villoria A, Garcia V, Dosal A, Moreno L, Montserrat A, Figuerola A, Horta D, Calvet X, Ramirez-Lazaro MJ. Fatigue in out-patients with inflammatory bowel disease: Prevalence and predictive factors. PLoS One. 2017 Jul 27;12(7):e0181435. doi: 10.1371/journal.pone.0181435. eCollection 2017.
- Horta D, Lira A, Sanchez-Lloansi M, Villoria A, Teggiachi M, Garcia-Rojo D, Garcia-Molina S, Figuerola A, Esteve M, Calvet X. A Prospective Pilot Randomized Study: Electroacupuncture vs. Sham Procedure for the Treatment of Fatigue in Patients With Quiescent Inflammatory Bowel Disease. Inflamm Bowel Dis. 2020 Feb 11;26(3):484-492. doi: 10.1093/ibd/izz091.
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Antecipado)
Conclusão Primária (Antecipado)
Conclusão do estudo (Antecipado)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- HMT3
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .